News > Article
Macular Degeneration Research

Macular Degeneration Research News: Fall 2022


Download PDF

In this issue:

  • President’s Corner
  • One-Time Gene Therapy for Wet AMD
  • DNA Modifcation and Gene Expression in AMD
  • New Treatments for AMD
  • Correcting Macular Degeneration Defects
  • Provide Security for Your Loved Ones…and Help Fight AMD

,

About BrightFocus Foundation

BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $300 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.

Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.

Share this post

News

Related Articles and Information

An older man sits on a couch with a glass of water in one hand and a pill pinched between the thumb and forefinger of the other, bringing the pill close to his mouth

Article

New Supplement to Prevent Macular Degeneration Inspires Deeper Search for Cures

A Macular Degeneration Research-funded scientist launched a supplement based on a link he discovered between the eye disease and Parkinson’s disease. Now he’s continuing research in the hopes of finding novel cures.

Daisy Shu, PhD

Article

Transforming Macular Degeneration Care With Long-Acting Treatment

With funding from Macular Degeneration Research, Dr. Daisy Shu is exploring advanced drug delivery systems that release medicine slowly over time. This innovative approach could reduce the number of injections needed for macular degeneration while maintaining vision-saving results.

Macular degeneration research wordmark.

Macular Degeneration Research News: Summer 2025

In this issue: Can Stem Cells Restore Vision Loss? Your Macula—How It Works and How to Protect It, Announcing $3.8 Million in Grants to Save Sight, and more!

Senior woman having an eye exam with her optometrist.

Article

How Targeting a Molecular ‘Switch’ Could Inspire New Macular Degeneration Treatments

A researcher funded by BrightFocus’ Macular Degeneration Research is zeroing in on a protein that damages eye cells in the early stages of dry age-related macular degeneration, offering insights that could lead to new treatments.

Portrait of smiling senior man with eyeglasses.

Article

How Better Models of Macular Degeneration Could Help Prevent Vision Loss

Most experimental models that researchers use to study macular degeneration fall short. BrightFocus Macular Degeneration Research grant recipient Dr. Brittany Carr aims to change that.

Macular degeneration research wordmark.

Article

Macular Degeneration Research News: Spring 2025

In this issue: How Exosomes Could Lead to Early Detection Before Symptoms Appear, Could a New Night Vision Test Save Sight? Inflammation and Gender Unlock Key Insights into Macular Degeneration, and more!

View All